Navigation Links
Cooling treatment for newborn asphyxia

Approximately 1 in 500 babies suffer from asphyxia, which can lead to brain injury, multiple disabilities or even death in severe cases. Around 25 per cent of babies who suffer from a moderate lack of oxygen at birth will develop cerebral palsy.// There are currently no effective treatments to reduce the risk of asphyxia at birth, but recent small scale studies have found that lowering a baby's temperature may have beneficial effects.

UK researchers are to investigate whether lowering a newborn baby's temperature by a few degrees can prevent the complications caused by asphyxia. Asphyxia can be caused by a number of factors, including an obstruction to the baby's blood supply or detachment of the placenta, however, in many cases the cause cannot be identified.

On the strength of these studies, researchers from hospitals and other medical institutions across the UK, with funding from the Medical Research Council, plan to undertake extensive trials to find out conclusively if this type of treatment can lessen asphyxia's serious effects.

During the study, parents of more than 200 children suffering from asphyxia will be asked to allow their infants to take part in the trial. Half the children will have their temperature cooled for a period of three days before being slowly returned to normal. The cooling procedure will involve a water-filled bed and be carried out by a nurse. It will not cause the babies any discomfort, and the infants will be closely monitored at all times.
'"/>




Page: 1

Related medicine news :

1. Cooling decreases heart attack effects
2. Stroke Patients May Benefit By Wearing Cooling Helmets
3. Cooling Can Reduce The Risk Of Brain Damage In Oxygen Deprived Newborns
4. Effect Of Cooling And Exercise To Be Analyzed In Patients With Multiple Sclerosis
5. Cooling Off As A Treatment Option For Heart And Trauma Patients
6. Survival After Cardiac Arrest Is Aided By Cooling
7. Current Cooling Devices Ineffective in Preventing Brain Injury
8. Existing Brain Cooling Not Beneficial To Trauma Patients
9. Cooling Towers may Cause Severe Respiratory Diseases
10. Cooling Temperatures Help Crucian Carp
11. Thyroid hormone treatment hastens recovery after cardiac surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... ... September 26, 2017 , ... Data Integrity: , The Key to FDA ... 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity , Consider this situation. ... electronic records may not be trustworthy and reliable … a more detailed evaluation may ...
(Date:9/26/2017)... Milford, PA (PRWEB) , ... September 26, 2017 , ... ... month in Chicago, called “The Magic of Fat,” revealed not only the latest about ... might prove to be an evolution in cosmetic medicine. , “Fat really is magical, ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Good Morning Sunshine!: Finding ... and overcoming obstacles. “Good Morning Sunshine!: Finding Strength and Comfort in God” is the ... psychology from Fort Hays Sate University, who has worked at a local mental health ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sonflower Submission”: a ... nature to the inevitable destinations of negativity, complaining and the need to always be ... take effect in order for a lesson in stress-less living to be learned. ...
(Date:9/26/2017)... ... ... out for Daddy is a moving story of a family's unconditional love for each ... for Daddy” is the creation of published author Debra Titus, who has lived in ... her to write this book. , Published by Christian Faith Publishing, Debra Titus’s new ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: